113. Muscular dystrophy
567 clinical trials,   442 drugs   (DrugBank: 93 drugs),   55 drug target genes,   151 drug target pathways

Other name(s) = "Dystrophinopathies", "Myotilinopathy", "Laminopathy", "Caveolinopathy", "LGMD1C", "Desminopathy", "Sarcoglycanopathy", "α-dystroglycanopathy", "FCMD", "Walker-Warburg syndrome", "Muscle-eye-brain disease", "Myotonic dystrophy", "Integrin α7 deficient CMD", "Rigid spine syndrome"

Specific pediatric chronic diseases, Japan
• 11-19-41. Duchenne muscular dystrophy
• 11-19-42. Emery-Dreifuss muscular dystrophy
• 11-19-43. limb-girdle muscular dystrophy
• 11-19-44. facio-scapulohumeral muscular dystrophy; FSMD
• 11-19-45. Fukuyama congenital muscular dystrophy; FCMD
• 11-19-46. merosin-deficient congenital muscular dystrophy
• 11-19-47. Ullrich congenital muscular dystrophy
• 11-19-48. Muscular dystrophy